NXSTAGE MEDICAL INC (NXTM) Stock Price, Forecast & Analysis

USA • Nasdaq • NASDAQ:NXTM • US67072V1035

30
+0.01 (+0.03%)
At close: Feb 21, 2019
30
0 (0%)
After Hours: 2/21/2019, 8:00:00 PM

NXTM Key Statistics, Chart & Performance

Key Statistics
Market Cap2.00B
Revenue(TTM)425.99M
Net Income(TTM)-5.50M
Shares66.69M
Float44.83M
52 Week High30
52 Week Low23.17
Yearly Dividend0
Dividend Yield0%
EPS(TTM)-0.08
PEN/A
Fwd PE136.36
Earnings (Next)N/A
IPON/A
Sector
GICS SectorN/A
GICS IndustryN/A
GICS IndustryGroupN/A
GICS SubIndustryN/A
NXTM short term performance overview.The bars show the price performance of NXTM in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months 1 2 3 4 5

NXTM long term performance overview.The bars show the price performance of NXTM in the last 1, 2 and 3 years. 1 year 2 years 3 years 5 10 15 20 25

The current stock price of NXTM is 30 null. In the past month the price increased by 5.49%. In the past year, price increased by 27.71%.

NXSTAGE MEDICAL INC / NXTM Daily stock chart

NXTM Technical Analysis

ChartMill assigns a technical rating of 9 / 10 to NXTM. When comparing the yearly performance of all stocks, NXTM is one of the better performing stocks in the market, outperforming 87.3% of all stocks.


Chartmill TA Rating
Chartmill Setup Rating

NXTM Fundamental Analysis

ChartMill assigns a fundamental rating of 5 / 10 to NXTM. NXTM has an average financial health and profitability rating.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

NXTM Financial Highlights

Over the last trailing twelve months NXTM reported a non-GAAP Earnings per Share(EPS) of -0.08. The EPS increased by 61.9% compared to the year before.


Industry RankSector Rank
PM (TTM) -1.29%
ROA -1.46%
ROE -2.44%
Debt/Equity 0
Chartmill High Growth Momentum
EPS Q2Q%107.14%
Sales Q2Q%11.13%
EPS 1Y (TTM)61.9%
Revenue 1Y (TTM)11.12%

NXTM Forecast & Estimates


Analysts
AnalystsN/A
Price TargetN/A
EPS Next Y95.45%
Revenue Next YearN/A

NXTM Ownership

Ownership
Inst Owners0%
Ins Owners0.08%
Short Float %N/A
Short RatioN/A

About NXTM

Company Profile

NxStage Medical, Inc. is a medical device company, headquartered in Lawrence, Massachusetts, USA, that develops, manufactures and markets innovative systems for the treatment of end-stage renal disease, or ESRD, and acute kidney failure.

Company Info

NXSTAGE MEDICAL INC

350 MERRIMACK STREET

LAWRENCE MA 01843

CEO: Jeffrey H. Burbank

Phone: 978-687-4700

NXSTAGE MEDICAL INC / NXTM FAQ

Can you describe the business of NXSTAGE MEDICAL INC?

NxStage Medical, Inc. is a medical device company, headquartered in Lawrence, Massachusetts, USA, that develops, manufactures and markets innovative systems for the treatment of end-stage renal disease, or ESRD, and acute kidney failure.


What is the stock price of NXSTAGE MEDICAL INC today?

The current stock price of NXTM is 30 null. The price increased by 0.03% in the last trading session.


Does NXTM stock pay dividends?

NXTM does not pay a dividend.


How is the ChartMill rating for NXSTAGE MEDICAL INC?

NXTM has a ChartMill Technical rating of 9 out of 10 and a ChartMill Fundamental rating of 5 out of 10.


How is the valuation of NXSTAGE MEDICAL INC (NXTM) based on its PE ratio?

NXSTAGE MEDICAL INC (NXTM) does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.08).


What is the market capitalization of NXTM stock?

NXSTAGE MEDICAL INC (NXTM) has a market capitalization of 2.00B null. This makes NXTM a Mid Cap stock.